195 related articles for article (PubMed ID: 20692450)
1. Frozen-section diagnosis in donor livers: error rate estimation of steatosis degree.
D'Alessandro E; Calabrese F; Gringeri E; Valente M
Transplant Proc; 2010; 42(6):2226-8. PubMed ID: 20692450
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of frozen-section analysis in the histological assessment of steatosis before liver transplantation.
Fiorentino M; Vasuri F; Ravaioli M; Ridolfi L; Grigioni WF; Pinna AD; D'Errico-Grigioni A
Liver Transpl; 2009 Dec; 15(12):1821-5. PubMed ID: 19938115
[TBL] [Abstract][Full Text] [Related]
3. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
4. The biopsied donor liver: incorporating macrosteatosis into high-risk donor assessment.
Spitzer AL; Lao OB; Dick AA; Bakthavatsalam R; Halldorson JB; Yeh MM; Upton MP; Reyes JD; Perkins JD
Liver Transpl; 2010 Jul; 16(7):874-84. PubMed ID: 20583086
[TBL] [Abstract][Full Text] [Related]
5. Reversal of graft steatosis after liver transplantation: prospective study.
Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
[TBL] [Abstract][Full Text] [Related]
6. Donor liver dysfunction: application of a new scoring system to identify the marginal donor.
Ferraz-Neto BH; Zurstrassen MP; Hidalgo R; Fonseca LE; Motta TD; Pandullo FL; Rezende MB; Meira-Filho SP; Sá JR; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2516-8. PubMed ID: 17954162
[TBL] [Abstract][Full Text] [Related]
7. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
8. Grade of deceased donor liver macrovesicular steatosis impacts graft and recipient outcomes more than the Donor Risk Index.
de Graaf EL; Kench J; Dilworth P; Shackel NA; Strasser SI; Joseph D; Pleass H; Crawford M; McCaughan GW; Verran DJ
J Gastroenterol Hepatol; 2012 Mar; 27(3):540-6. PubMed ID: 21777274
[TBL] [Abstract][Full Text] [Related]
9. Effect of graft steatosis on liver function and organ survival after liver transplantation.
Angele MK; Rentsch M; Hartl WH; Wittmann B; Graeb C; Jauch KW; Loehe F
Am J Surg; 2008 Feb; 195(2):214-20. PubMed ID: 18154767
[TBL] [Abstract][Full Text] [Related]
10. Successful use of extended criteria donor grafts with low to moderate steatosis in patients with model for end-stage liver disease scores below 27.
Avolio AW; Frongillo F; Nicolotti N; Mulè A; Vennarecci G; De Simone P; Agnes S
Transplant Proc; 2009; 41(1):208-12. PubMed ID: 19249515
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience gained from the use of 120 steatotic donor livers for orthotopic liver transplantation.
Verran D; Kusyk T; Painter D; Fisher J; Koorey D; Strasser S; Stewart G; McCaughan G
Liver Transpl; 2003 May; 9(5):500-5. PubMed ID: 12740794
[TBL] [Abstract][Full Text] [Related]
12. Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients.
Burra P; Loreno M; Russo FP; Germani G; Galligioni A; Senzolo M; Cillo U; Zanus G; Fagiuoli S; Rugge M
Liver Transpl; 2009 Jun; 15(6):619-28. PubMed ID: 19479805
[TBL] [Abstract][Full Text] [Related]
13. Assessment of hepatic steatosis by transplant surgeon and expert pathologist: a prospective, double-blind evaluation of 201 donor livers.
Yersiz H; Lee C; Kaldas FM; Hong JC; Rana A; Schnickel GT; Wertheim JA; Zarrinpar A; Agopian VG; Gornbein J; Naini BV; Lassman CR; Busuttil RW; Petrowsky H
Liver Transpl; 2013 Apr; 19(4):437-49. PubMed ID: 23408461
[TBL] [Abstract][Full Text] [Related]
14. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
15. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?
Hałoń A; Patrzałek D; Rabczyński J
Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700
[TBL] [Abstract][Full Text] [Related]
16. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
[TBL] [Abstract][Full Text] [Related]
17. One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
Ryan CK; Johnson LA; Germin BI; Marcos A
Liver Transpl; 2002 Dec; 8(12):1114-22. PubMed ID: 12474149
[TBL] [Abstract][Full Text] [Related]
18. Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation.
Botha JF; Thompson E; Gilroy R; Grant WJ; Mukherjee S; Lyden ER; Fox IJ; Sudan DL; Shaw BW; Langnas AN
Liver Int; 2007 Aug; 27(6):758-63. PubMed ID: 17617118
[TBL] [Abstract][Full Text] [Related]
19. Safety of donors with fatty liver in liver transplantation.
Kwon CH; Joh JW; Lee KW; Kim SJ; Han YS; Park JW; Kim DJ; Park JB; Lee SK
Transplant Proc; 2006 Sep; 38(7):2106-7. PubMed ID: 16980014
[TBL] [Abstract][Full Text] [Related]
20. Steatosis in donor and transplant liver biopsies.
Crowley H; Lewis WD; Gordon F; Jenkins R; Khettry U
Hum Pathol; 2000 Oct; 31(10):1209-13. PubMed ID: 11070113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
